Lychix is an innovative high-tech enterprise founded in 2018 by two doctoral graduates who returned from the United States. The company focuses on independent research and development of high-end life science instruments and core technologies, providing advanced research tools for the life sciences, and is committed to developing efficient technology platforms to mine massive high-resolution life science data. With outstanding innovation capability and clear market potential, the company has received support from well-known investment institutions such as IDG Capital and Legend Capital, with cumulative financing reaching hundreds of millions of RMB. The company's main business focuses on two major directions: high-end life science and in vitro diagnostics (IVD) solutions.
1. High-end life science solutions (representative products)
Single-cell light-guided system: This system is mainly used in frontier immunology research fields such as antibody discovery, cell therapy, vaccine development, and cell line construction. Its product performance has been validated by the market, adopted by many academic institutions and well-known pharmaceutical companies, and has set a record for the procurement amount of a single unit of domestic life science instruments.
Full-spectrum flow cytometry system: As another blockbuster high-end single-cell analysis/sorting platform launched by Lychix, it adopts innovative spectral design and high-precision full-spectrum analysis technology, enabling high-dimensional analysis/sorting of cells in samples one by one, significantly improving spectral resolution and detection sensitivity. It has built-in four spectral analysis algorithms, allowing selection of unmixing schemes for different experimental scenarios, and supports one-click free switching between traditional and full-spectrum modes, providing a powerful tool for complex multi-dimensional research in fields such as immunology and oncology.
2. In vitro diagnostics (IVD) solutions
Single-molecule immunoassay system: As the company's core product in the field of precision medicine, this instrument has ultra-high detection sensitivity at the fg/ml level and can accurately measure extremely low concentrations of biomarkers in blood. Currently, its core clinical application focuses on early screening and auxiliary differential diagnosis of Alzheimer's disease. The instrument and its supporting detection reagents have obtained Class II medical device registration certificates issued by China's National Medical Products Administration (NMPA), and have been put into clinical use in many leading tertiary Grade A hospitals and high-end physical examination centers in China, gaining high clinical recognition for their excellent detection performance.
What does Caike (Suzhou) Biotechnology Co., Ltd. require? Who is Caike (Suzhou) Biotechnology Co., Ltd. hiring? recruitment: Sales占比最多占28.4%,其次是Mechanical/Instrumentation占22.4%. What education can get in at ? 硕士占比最多占53.4%,其次是本科占39.7%. High education required at ? 硕士占53.4%,博士占0.9%. Work experience required at ? 不限占比最多占32.8%,其次是1-3年占28.4%. Where are the job locations at ? 苏州占比最多占62.9%,其次是北京占11.2%. Based on job postings from the past year, for reference only.
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows